NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in NRX Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +6 vs. Q2 2021
- Shares held
- 1.75M
- +114.0K (+7.0%) vs. Q2 2021
- Total value
- $16.2M
- −$2.70M (−14.3%) vs. Q2 2021
- New holders
- 14
- 7 more added
- Sold out
- 8
- 1 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRXP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $47.6M |
| Q1 2026 | 33 | $13.2M |
| Q4 2025 | 28 | $14.2M |
| Q3 2025 | 24 | $13.0M |
| Q2 2025 | 25 | $9.76M |
| Q1 2025 | 22 | $4.60M |
| Q4 2024 | 25 | $2.31M |
| Q3 2024 | 18 | $1.21M |
| Q2 2024 | 19 | $1.29M |
| Q1 2024 | 31 | $1.76M |
| Q4 2023 | 30 | $1.84M |
| Q3 2023 | 34 | $964.7K |
| Q2 2023 | 32 | $4.78M |
| Q1 2023 | 30 | $2.07M |
| Q4 2022 | 33 | $3.44M |
| Q3 2022 | 30 | $3.04M |
| Q2 2022 | 37 | $2.18M |
| Q1 2022 | 34 | $25.1M |
| Q4 2021 | 38 | $12.4M |
| Q3 2021 | 23 | $16.2M |
| Q2 2021 | 18 | $18.9M |
| Q1 2021 | 1 | $4.00K |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding NRX Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 212 | $2.00K | 0.00% | +212 | New |
| Larson Financial Group LLC | 218 | $2.00K | 0.00% | +218 | New |
| Citigroup Inc | 479 | $4.00K | 0.00% | +394+463.5% | Added |
| Jacobi Capital Management LLC | 1,000 | $9.00K | 0.00% | +1,000 | New |
| Tower Research Capital LLC (TRC) | 1,026 | $10.0K | 0.00% | +895+683.2% | Added |
| Quantbot Technologies LP | 1,565 | $14.0K | 0.00% | +1,565 | New |
| Penserra Capital Management LLC | 2,956 | $27.0K | 0.00% | +2,956 | New |
| Wells Fargo & Company | 5,000 | $46.0K | 0.00% | +5,000 | New |
| Cutler Group LP | 7,451 | $69.0K | 0.01% | +7,451 | New |
| Group One Trading, L.P. | 7,574 | $70.0K | 0.00% | +7,574 | New |
| Murchinson Ltd. | 17,900 | $166.0K | 0.08% | +17,900 | New |
| Bank of America Corp | 19,362 | $179.0K | 0.00% | +19,362 | New |
| Morgan Stanley | 41,052 | $381.0K | 0.00% | +1,183+3.0% | Added |
| Wolverine Asset Management LLC | 42,568 | $394.0K | 0.00% | +23,078+118.4% | Added |
| Advisor Group Holdings, Inc. | 42,885 | $398.0K | 0.00% | +39,580+1,197.6% | Added |
| HighPoint Advisor Group LLC | 43,501 | $403.0K | 0.04% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 45,766 | $424.0K | 0.00% | +11,291+32.8% | Added |
| Owl Creek Asset Management, L.P. | 50,000 | $464.0K | 0.03% | −250,000−83.3% | Reduced |
| Susquehanna International Group, LLP | 55,328 | $513.0K | 0.00% | +55,328 | New |
| Jane Street Group, LLC | 77,032 | $714.0K | 0.00% | +77,032 | New |
| Citadel Advisors LLC | 135,087 | $1.25M | 0.00% | +135,087 | New |
| Cambridge Investment Research Advisors, Inc. | 153,523 | $1.42M | 0.01% | +153,523 | New |
| Vanguard Group Inc | 1,000,123 | $9.27M | 0.00% | +362,707+56.9% | Added |
| Linden Advisors LP | 0 | $0 | 0.00% | −364,352−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −130,633−100.0% | Sold out |
| Ionic Capital Management LLC | 0 | $0 | 0.00% | −35,721−100.0% | Sold out |
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −11,923−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −8,385−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Stonebridge Financial Planning Group, LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |